Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Meetings, Planning and Dissemination Grant: PHSI

University of British Columbia

$15,000.00

Magnesium Sulfate for Prevention of Cerebral Palsy in Preterm Infants

FY 2009-10

Summary
In conjunction with the Society of Obstetricians and Gynaecologists of Canada (SOGC), we will meet to (i) reach national consensus on the quality of the evidence for antenatal MgSO4 for fetal neuroprotection in women at high-risk for preterm delivery; (ii) write a SOGC Clinical Practice Guideline/Policy Statement for maternity care providers, on the risks and benefits and clinical recommendations of MgSO4 for fetal neuroprotection in the setting of threatened preterm birth; and (iii) plan national implementation of the SOGC Guideline/Statement within a quality assurance framework. This would require collaboration of researchers (CPN, CNN, CNFUN, MICare, CPSN) and decision makers (SOGC, Health Canada, CPPC). This knowledge translation strategy would be submitted for funding to the June, 2010 PHSI Competition.
Program
Meetings, Planning and Dissemination Grant: PHSI
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
193083
Name
Magee Laura A
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Meetings, Planning and Dissemination Grant: Partnerships for Health System Improvement
Projecttitle
Magnesium Sulfate for Prevention of Cerebral Palsy in Preterm Infants
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$15,000
Cihrequipment2
$0
Programname2
Meetings, Planning and Dissemination Grant: PHSI
Keyworddelim
Cerebral Palsy; Magnesium Sulfate; Neuroprotection; Preterm Birth
Abstract
In conjunction with the Society of Obstetricians and Gynaecologists of Canada (SOGC), we will meet to (i) reach national consensus on the quality of the evidence for antenatal MgSO4 for fetal neuroprotection in women at high-risk for preterm delivery; (ii) write a SOGC Clinical Practice Guideline/Policy Statement for maternity care providers, on the risks and benefits and clinical recommendations of MgSO4 for fetal neuroprotection in the setting of threatened preterm birth; and (iii) plan national implementation of the SOGC Guideline/Statement within a quality assurance framework. This would require collaboration of researchers (CPN, CNN, CNFUN, MICare, CPSN) and decision makers (SOGC, Health Canada, CPPC). This knowledge translation strategy would be submitted for funding to the June, 2010 PHSI Competition.
Competitiondate
200910
Approvedterm2
1 yr 0 mth
Pinamesdelim
Magee, Laura A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $15,000~ $0~